02-2225-1234
폐암, 두경부암, 식도암, 뇌 종양
| 구분 | 월 | 화 | 수 | 목 | 금 | 토 |
|---|---|---|---|---|---|---|
| 오전 | 진료가능 | 진료가능 | 진료가능 | |||
| 오후 | 진료가능 |

- 최근 5년간의 자료
| 2026/01 | 교신저자 | Annals of Laboratory Medicine | Association of ASXL1 and RUNX1 Variants with Splenomegaly in Myelodysplastic Syndromes Based on Next-generation Sequencing and Computed Tomography Data: A Retrospective Study |
|---|---|---|---|
| 2025/01 | 교신저자 | Frontiers in Immunology | High-dose ascorbic acid synergizes with anti-PD1 therapy in non-small cell lung cancer in vitro and in vivo models |
| 2024/01 | 교신저자 | Oncology letters | Intrahepatic cholangiocarcinoma initially diagnosed with adenocarcinoma of unknown primary with Hepatoduodenal ligament lymph node metastases: A case report |
| 2023/08 | 교신저자 | Cancers | Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer |
| 2023/08 | 공동저자 | Journal of The Korean Neurological Association | 범혈구감소증 환자에서 보이는 급성 파종뇌미세출혈 |
| 2023/02 | 교신저자 | Medicina | Long-Term Response of Pembrolizumab in a Patient with Metastatic Squamous Non-Small Cell Lung Cancer on Hemodialysis: Case Report and Review of the Literature |
| 2022/01 | 공동저자 | Cancer research and treatment | Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations |
- 최근 3년간의 자료
이 페이지에서 제공하는 정보에 대하여 어느 정도 만족하셨습니까?